Amanta Healthcare IPO GMP, Price, Allotment, Profit Estimate 2025

Amanta Healthcare IPO Description – Amanta Healthcare is a pharmaceutical company specializing in sterile liquid products, including Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs), manufactured using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. As of 31 December 2024, the company operates four LVP and three SVP manufacturing lines at its WHO-GMP certified, 66,852 sq. meter facility in Hariyala, District Kheda, Gujarat.

It produces over 45 generic products across six therapeutic segments such as fluid therapy, ophthalmics, respiratory care, and irrigation solutions, offering container fill volumes from 2ml to 1000ml with diverse closure systems. The company employs 1,727 personnel, including 509 full-time staff, and maintains a dedicated Formulation & Development (F&D) and quality control lab staffed by 128 professionals.

Its international presence spans 19 countries with 47 products registered across 112 jurisdictions. Domestically, it operates through a distribution network of over 316 stockists, supported by an 108-member sales team. Amanta also partners with Indian and global pharmaceutical firms for commercial-scale manufacturing and license agreements, positioning itself as a trusted player in sterile injectable manufacturing.

Promoters of Amanta Healthcare – Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendrakumar Patel, and Milcent Appliances Private Limited

Amanta Healthcare IPO Details

Amanta Healthcare IPO Dates	1 – 3 September 2025
Amanta Healthcare IPO Price	Coming soon
Fresh issue	1,00,00,000 shares
Offer For Sale	Nil
Total IPO size	1,00,00,000 shares
Minimum bid (lot size)	Coming soon
Face Value	INR 10 per share
Retail Allocation	35%
Listing On	NSE, BSE

Amanta Healthcare Financial Performance

	FY 2023	FY 2024	FY 2025
Revenue	259.13	280.34	274.71
Expenses	206.39	222.85	215.04
Net income	(2.11)	3.62	10.50
Margin (%)	(0.81)	1.29	3.82

Figures in INR Crores unless specified otherwise

Amanta Healthcare Offer News

Amanta Healthcare Valuations & Margins

	FY 2023	FY 2024	FY 2025 (Pre-Issue)	FY 2025 (Post-Issue)*
EPS	(0.79)	1.35	3.71	–
PE Ratio	–	–	–	–

* Calculated on the basis of annualized Profits After Tax for FY 2025

	FY 2023	FY 2024	FY 2025
RONW (%)	(3.36)	5.48	10.89
NAV	23.44	24.71	33.43
ROCE (%)	12.19	12.76	13.72
EBITDA (%)	21.43	20.86	22.11
Debt/Equity	3.43	3.10	2.02

*Compiled by IPO Central from Prospectus

Amanta Healthcare IPO GMP Today (Daily Trend)

Amanta Healthcare IPO Objectives

The company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:

Funding capital expenditure requirements for civil construction work and towards the purchase of equipment, plant and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat – INR 70 crore
Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat – INR 30.13 crore
General corporate purposes

Amanta Healthcare IPO Subscription – Live Updates

Coming soon

NA shares allotted to anchor investors are not included in these calculations.

Amanta Healthcare – Comparison With Listed Peers

Company	PE ratio	EPS	RONW (%)	NAV	Revenue (Cr.)
Amanta Healthcare	–	3.71	10.89	33.43	276.09
Denis Chem Lab	15.92	5.82	9.49	61.33	175.67

Amanta Healthcare IPO Allotment Status

Amanta Healthcare IPO allotment status will be on MUFG Intime’s website. Click on this link to get the allotment status.

Amanta Healthcare IPO Dates & Listing Performance

IPO Opening Date	1 September 2025
IPO Closing Date	3 September 2025
Finalization of Basis of Allotment	4 September 2025
Initiation of refunds	5 September 2025
Transfer of shares to demat accounts	5 September 2025
Amanta Healthcare IPO Listing Date	8 September 2025
Opening Price on NSE	Coming soon
Closing Price on NSE	Coming soon

Angel One –
Anand Rathi –
Antique Stock Broking –
Ajcon Global –
Arihant Capital –
Axis Capital –
Ashika Research –
BP Wealth –
Capital Market –
Canara Bank Securities –
Choice Broking –
Dalal & Broacha –
Elara Capital –
Elite Wealth –
GCL Broking –
Geojit –
GEPL Capital –
Hem Securities –
Hensex Securities –
HDFC Securities –
ICICIdirect –
IDBI Capital –
Investmentz –
Indsec Securities –
Jainam Broking –
KR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Mehta Equities –
Nirmal Bang –
Reliance Securities –
Sushil Finance –
Samco Securities –
SBI Securities –
SMC Global –
SMIFS –
Systematix Research –
Swastika Investmart –
Ventura Securities –

Amanta Healthcare Offer Lead Manager

BEELINE CAPITAL ADVISORS PRIVATE LIMITED
B 1311-1314, Thirteenth Floor, Shilp Corporate Park,
Rajpath Rangoli Road, Thaltej,
Ahmedabad- 380054, Gujarat, India
Phone: 079 4918 5784
Email: [email protected]
Website: www.beelinemb.com

Amanta Healthcare Offer Registrar

MUFG INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone: +91 810 811 4949
Email: [email protected]
Website: www.in.mpms.mufg.com

AMANTA HEALTHCARE LIMITED
8th Floor, Shaligram Corporates, C.J. Marg,
Ambli, Ahmedabad – 380058, Gujarat, India
Phone: 079 67777600
Email: [email protected]
Website: www.amanta.co.in

Amanta Healthcare IPO FAQs

How many shares in Amanta Healthcare IPO are reserved for HNIs and retail investors?

The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.

How to apply for the Amanta Healthcare Public Offer?

The best way to apply for Amanta Healthcare public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stockbroker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.